Stem cell-based cell therapy in neurological diseases: A review

Journal of Neuroscience Research

Volumn 87, Issue 10, 2009, Pages 2183-2200

  Kim, Seung U ^a,b   de Vellis, Jean ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Chung Ang University College of Medicine   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell therapy; Embryonic stem cell; Gene transfer; Mesenchymal stem cell; Neural stem cell; Neurological disease; Stem cell; Transplantation

Indexed keywords

ADENOVIRUS VECTOR; BETA INTERFERON; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINESTERASE INHIBITOR; CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; INTERLEUKIN 12; INTERLEUKIN 4; IRINOTECAN; LEVODOPA; MINOCYCLINE; NERVE GROWTH FACTOR; NEUROGENIN 2; NEUROTROPHIN; RETINOIC ACID; RETROVIRUS VECTOR; SONIC HEDGEHOG PROTEIN; TYROSINE 3 MONOOXYGENASE; VASCULOTROPIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BLOOD BRAIN BARRIER; BRAIN INFARCTION; BRAIN TRANSPLANTATION; BRAIN TUMOR; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; EMBRYONIC STEM CELL; EX VIVO GENE TRANSFER; FETAL TISSUE TRANSPLANTATION; GLIOBLASTOMA; GLIOMA; HUMAN; HUNTINGTON CHOREA; LYSOSOME STORAGE DISEASE; MEDULLOBLASTOMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL TRANSPLANTATION; NEUROBLASTOMA; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REMYELINIZATION; REVIEW; SPINAL CORD INJURY; STEM CELL GENE THERAPY; STEM CELL TRANSPLANTATION; VIRAL GENE THERAPY; ANIMAL; BIOLOGICAL THERAPY; CLASSIFICATION; METHODOLOGY; PHYSIOLOGY; STEM CELL;

ANIMALS; HUMANS; NERVOUS SYSTEM DISEASES; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE THERAPY;

EID: 69249220421     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22054     Document Type: Review

References (216)

1. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO, Snyder EY. 2000. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 97:12846-12851.
2. Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, Justus KA, Phelps DA, Remack JS, Yoon KJ, Gillespie S, Kim SU, Glackin CA, Potter PM, Danks MK. 2006. Human neural stemcells target human primary and metastatic cancers in animal models: potential therapeutic applications. PLoS One 1/ e54:1-11.
3. Aboody KS, Najbauer J, Danks MK. 2008. Neural stem cell mediated tumor- selective gene delivery: towards high grade glioma clinical trials. Mol Ther 16(Suppl 1):S136.
4. Agid Y. 1991. Parkinson's disease: pathophysiology. Lancet 337:1321-1324.
5. Akiyama Y, Radke C, Kocsis JD. 2002. Remyelination of rat spinal cord by implantation of identified bone marrow stromal cells. J Neurosci 22:6623-6630.
6. Alston TA, Mela L, Bright HJ. 1977. 3-Nitropropionic acid, the toxic substance of Indiuofera, is a suicide inactivator of succinic dehydrogenase. Proc Natl Acad Sci USA 74:3767-3771.
7. Anton R, Kordower JH, Maidment NT, Manaster JS, Kane DJ, Rabizadeh S, Schueller SB, Yang J, Rabizadeh S, Edwards RH. 1994. Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp Neurol 127:207-218.
8. Armstrong RJ, Watts C, Svendsen CN, Dunnett SB, Rosser AE. 2000. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant 9:55-64.
9. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, Carmeliet P, Mazarakis ND. 2004. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429:413-417.
10. Bachoud-Lévi AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boissé MF, Grandmougin T, Jény R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M. 2000. Motor and cognitive improvements in patients with Huntington's disease after neural transplnatation. Lancet 356:1975-1979.
11. Bales KR, Tzavara ET, Wu S, Wade MR, Bymaster FP, Paul SM, Nomikos GG. 2006. Cholinergc dysfunction in a mouse model of Alzheimer disease is reversed by an anti-Aβ antibody. J Clin Invest 116:825-832.
12. Barresi V, Belluardo N, Sipione S, Mudò G, Cattaneo E, Condorelli DF. 2003. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther 10:396-402.
13. Bartus R, Dean RL, Beer B, Lippa AS. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-411.
14. Basso DM, Beattie MS, Bresnahan JC. 1996. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244-256.
15. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181-4192.
16. Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM. 2001. Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metaloproteinase-2. Cancer Res 61:8730-8736.
17. Bemelmans AP, Horellou P, Pradier L, Brunet I, Colin P, Mallet J. 1999. Brain-derived neurotrophic fator-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer. Hum Gene Ther 10:2987-2997.
18. Bencsics C, Wachtel SR, Milstien S, Hatakeyama K, Becker JB, Kang UJ. 1996. Double transduction with GTP cyclohydrolase1 and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts. J Neurosci 16:4449-4456.
19. Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D, Galli R, Selleri S, Di Meco F, De Fraja C, Vescovi A, Cattaneo E, Finocchiaro G. 2000. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 6:447-450.
20. Ben-Hur T, Einstein O, Mizrachi-Kol R, Ben-Menachem O, Reinhartz E, Karussis D, Abramsky O. 2003. Transplanted multipotential neural progenitor cells migrate into the inflamed white matter in response to experimental allergic encephalitis. Glia 41:73-80.
21. Benn SC, Woolf CJ. 2004. Adult neuron survival strategies - slamming on the brakes. Nat Rev Neurosci 5:686-700.
22. Bjorklund A, Lindvall O. 2000. Cell replacement therapies for central nervous system disorders. Nat Neurosci 3:537-544.
23. Black PM, Loeffler J. 1997. Cancer of the nervous system. Oxford: Blackwell.
24. Bouillee S, Van de Velde C, Cleveland DW. 2006. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59.
25. Borlongan CV, Tajima Y, Trojanowski JQ, Lee VM, Sanberg PR. 1998. Transplantation of cryopreserved human embryonic carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 149:310-321.
26. Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF. 1995. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal movements in primates. Proc Natl Acad Sci USA 92:7105-7109.
27. Brustle O, McKay RG. 1996. Neuronal progenotors as tools for cell replacement in the nervous system. Curr Opin Neurobiol 6:688-695.
28. Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, Duncan ID, McKay RD. 1999. Embryonic stem cell-derived glial precursors: a source for myelinating transplants. Science 285:754-756.
29. Bunge RP, Puckett WR, Becerra JL, Marcillo A, Quencer RM. 1993. Observations on the pathology of human spinal cord injury. Adv Neurol 59:75-89.
30. Cao QL, Howard RM, Dennison JB, Whittemore SR. 2002. Differentiation of engrafted neuronalrestricted precursor cells is inhibited in the traumatically injured spinal cord. Exp Neurol 177:349-359.
31. Cao Q, Xu XM, Devries WH, Enzmann GU, Ping P, Tsoulfas P, Wood PM, Bunge MB, Whittemore SR. 2005. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 25:6947-6957.
32. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. 2001. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682-2688.
33. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M. 2003. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73:778-786.
34. Chu K, Kim M, Jeong SW, Kim SU, Yoon BW. 2003. Human neural stem cells can migrate, differentiate and integrate after intravenous transplantation in adult rats with transient forbrain ischemia. Neurosci Lett 343:637-643.
35. Chu K, Park KI, Lee ST, Jung KH, Ko SY, Kang L, Sinn DI, Lee YS, Kim SU, Kim M, Roh JK. 2005. Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia. Neurosci Res 53:384-390.
36. Chung S, Sonntag KC, Andersson T, Bjorklund LM, Park JJ, Kim DW, Kang UJ, Isacson O, Kim KS. 2002. Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur J Neurosci 16:1829-1838.
37. Copray S, Balasubramaniyan V, Levenga J, de Bruijn J, Liem R, Boddeke E. 2006. Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes. Stem Cells 24:1001-1010.
38. Coyle JT, Price DL, DeLong MR. 1983. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184-1190.
39. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. 1997. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3:73-76.
40. Cummings BJ, Uchida N, Tamaki SJ, Salazar DL, Hooshmand M, Summers R, Gage FH, Anderson AJ. 2005. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci USA 102:14069-14074.
41. Danks MK, Yoon KJ, Bush RA, Remack JS, Wierdl M, Tsurkan L, Kim SU, Garcia E, Metz MZ, Najbauer J, Potter PM, Aboody KS. 2007. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res 67:22-25.
42. Dickson PV, Hamner JB, Burger RA, Garcia E, Ouma AA, Kim SU, Ng CY, Gray JT, Aboody KS, Danks MK, Davidoff AM. 2007. Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of IFN-β and restricts tumor growth in a murine model of disseminated neuroblastoma. J Pediatr Surg 42:48-53.
43. DiFiglia M. 1990. Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci 13:286-289.
44. Donovan PJ, Gearhart J. 2001. The end of beginning for pluripotent stem cells. Nature 414:92-98.
45. Dunn IF, Black PM. 2003. The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy. Neurosurgery 52:1411-1422.
46. Dunnett SB, Bjorklund A. 1999. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399:A32-A39.
47. Dunnett SB, Carter RJ, Watts C, Torres EM, Mahal A, Mangiarini L, Bates G, Morton AJ. 1998. Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp Neurol 154:31-40.
48. During MJ, Naegele JR, O'Malley KL, Geller AI. 1994. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399-1403.
49. Ebers GC. 1988. Multiple scelrosis and other demyelinating diseases. In: Asbury A, McKhann G, McDonald W, editors. Diseases of the nervous system. Philadelphia: W.B. Saunders. p 1268-1291.
50. Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS. 2002a. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 62:5657-5663.
51. Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, Yu JS. 2002b. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 62:7170-7174.
52. Emerich DF, Winn SR, Harper J, Hammang JP, Baetge EE, Kordower JH. 1994. Implants of polymer-encapsulated human NGF-secreting cells in the non-human primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol 349:148-164.
53. Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. 1998. Neurogenesis in the adult human hippocampus. Nat Med 4:1313-1317.
54. Espinosa de los Monteros A, Zhao P, Huang C, Pan T, Chang R, Nazarian R, Espejo D, de Vellis J. 1997. Transplantation of CG4 oligodendrocyte progenitor cells in the myelin-deficient rat brain results in myelination of axons and enhanced oligodendroglial markers. J Neurosci Res 50:872-887.
55. Espinosa de los Monteros A., Baba H, Zhao PM, Pan T, Chang R, de Vellis J, Ikenaka K. 2001. Remyelination of the adult demyelinated mouse brain by grafted oligodendrocyte progenitors. Neurochem Res 26:673-682.
56. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S. 2003. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta protein and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100:4162-4167.
57. Fehlings MG, Tator CH. 1995. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol 132:220-228.
58. Fischer W, Wictorin K, Björklund A, Williams LR, Varon S, Gage FH. 1987. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329:65-68.
59. Fisher LJ, Jinnah HA, Kale LC, Higgins GA, Gage FH. 1991. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-DOPA. Neuron 6:371-380.
60. Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendoubi M, Sidman RL, Wolfe JH, Kim SU, Snyder EY. 1998. Engraftable human neural stem cells respond to developmental cues, replace neurons and express foreign genes. Nat Biotechnol 16:1033-1039.
61. Franklin RJ, Blakemore WF. 1997. Transplanting oligodendrocyte progenitors into the adult CNS. J Anat 190:23-33.
62. Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, Nauert GM, Sanberg PR, Kordower JH, Saporta S, Isacson O. 2000. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci USA 97:13877-13882.
63. Gage FH. 2000. Mammalian neural stem cells. Science 287:1433-1438.
64. Garbuzova-Davis S, Willing AE, Milliken M, Saporta S, Zigova T, Cahill DW, Sanberg PR. 2002. Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis. Exp Neurol 174:169-180.
65. Glaser T, Perez-Bouza A, Klein K, Brustle O. 2005. Generation of purified oligodendrocyte progenitors from embryonic stem cells. FASEB J 19:112-114.
66. Goldman S. 2005. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 7:862-871.
67. Gottlieb DI. 2002. Large scale sources of neural stem cells. Annu Rev Neurosci 25:381-407.
68. Graham ML, Herndon JE, Casey JR, Chaffee S, Ciocci GH, Krischer JP, Kurtzberg J, Laughlin MJ, Longee DC, Olson JF, Paleologus N, Pennington CN, Friedman HS. 1997. Highdose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 15:1814-23.
69. Greenmayre JT, Shoulson I. 1994. Huntington disease. In: Calne D, editor. Neurodegenrative disease. Philadelphia: W.B. Saunders. p 658-704.
70. Guest JD, Hiester ED, Bunge RP. 2005. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp Neurol 192:384-393.
71. Gumpel M, Lachapelle F, Gansmuller A, Baulac M, Baron van Evercooren A, Baumann N. 1987. Transplantation of human embryonic oligodendrocytes into shiverer brain. Ann NY Acad Sci 495:71-85.
72. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. 1994. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-1775.
73. Hagell P, Brundin P. 2002. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson's disease. J Neuropathol Exp Neurol 60:741-752.
74. Hagell P, Schrag A, Piccini P, Jahanshahi M, Brown R, Rehncrona S, Widner H, Brundin P, Rothwell JC, Odin P, Wenning GK, Morrish P, Gustavii B, Björklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O. 1999. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122:1121-1132.
75. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356.
76. Harper PS. 1996. Huntington's disease. Philadelphia: W.B. Saunders.
77. Harper JM, Krishnan C, Darman JS. 2004. Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci USA 101:7123-7128.
78. Harris GJ, Codori AM, Lewis RF, Schmidt E, Bedi A, Brandt J. 1999. Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease. Brain 122:1667-1678.
79. Hefti F. 1986. NGF promotes survival of septal cholinergic neurons after fimbrial transection. J Neurosci 6:2155-2161.
80. Hemming ML, Patterson M, Reske-Nielsen C, Lin L, Isacson O, Selkoe DJ. 2007. Reducing amyloid plaque burden via ex vivo gene delivery of an Aβ-degrading protease: a novel therapeutic approach to Alzheimer disease. PLoS Med 4/e262:1405-1416.
81. Herrlinger U, Woiciechowski C, Sena-Esteves M, Aboody KS, Jacobs AH, Rainov NG, Snyder EY, Breakefield XO. 2000. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther 4:347-57.
82. Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ, Olson L. 2002. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 99:2199-2204.
83. Hoshimaru M, Ray J, Sah DW, Gage FH. 1996. Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene. Proc Natl Acad Sci USA 93:1518-1523.
84. Hudson AJ. 1990. Amyotrophic lateral sclerosis: concepts in pathogenesis and etiology. Toronto: University of Toronto Press.
85. Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
86. Hwang DH, Lee HJ, Seok JI, Kim BG, Joo IS, Kim SU. 2009. Intrathecal transplantation of human neural stem cells over-expressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther (in press).
87. Iwanami A, Kaneko S, Nakamura M, Kanemura Y, Mori H, Kobayashi S, Yamasaki M, Momoshima S, Ishii H, Ando K, Tanioka Y, Tamaoki N, Nomura T, Toyama Y, Okano H. 2005. Transplantation of human neural stem cells for spinal cord injury in primates. J Neurosci Res 80:182-190.
88. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC. 2001. Metablic regulation of brain Abeta by neprilysin. Science 292:1550-1562.
89. Jeong SW, Chu K, Kim MH, Kim SU, Roh JK. 2003. Human neural stem cell transplantation in experimental intracerebral hemorrhage. Stroke 34:2258-2263.
90. Jiao S, Gurevich V, Wolff JA. 1993. Long-term correction of rat model of Parkinson's disease by gene therapy. Nature 362:450-453.
91. Kang UJ, Fisher LJ, Joh TH, O'Malley KL, Gage FH. 1993. Regulation of dopamine production by genetically modified primary fibroblasts. J Neurosci 13:5203-5211.
92. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Morshead CM, Fehlings MG. 2006. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci 26:3377-3389.
93. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, Sasai Y. 2000. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28:31-40.
94. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O. 2005. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4694-4705.
95. Kerr DA, Lladó J, Shamblott MJ, Maragakis NJ, Irani DN, Crawford TO, Krishnan C, Dike S, Gearhart JD, Rothstein JD. 2003. Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci 23:5131-5140.
96. Kim BG, Hwang DH, Lee SI, Kim SU. 2007. Stem cell-based cell therapy for spinal cord injury. Cell Transplant 16:355-364.
97. Kim JH, Auerbach JM, Rodríguez-Gómez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sánchez-Pernaute R, Bankiewicz K, McKay R. 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418:50-56.
98. Kim M, Lee ST, Chu K, Kim SU. 2008. Stem cell-based cell therapy for Huntington disease: a review. Neuropathology 28:1-9.
99. Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al-Hashem R, Kim SU, Black PM, Carroll RS. 2005. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 11:5965-5970.
100. Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon LG, Black PM, Carroll RS. 2006. Human neural stem cells target experiemntal intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 12: 5550-5556.
101. Kim SU. 2004. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 24:159-174.
102. Kim SU, Park IH, Kim TH, Kim KS, Choi HB, Hong SH, Bang JH, Lee MA, Joo IS, Lee KS, Kim YS. 2006. Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease. Neuropathology 26:129-140.
103. Kim SU, Hwang DH, Kim BG, Park IH, Joo IS. 2008a. Human neural stem cells over-expressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Mol Ther 16(Suppl 1):S32.
104. Kim SU, Nagai A, Nakagawa E, Choi HB, Bang JH, Lee HJ, Lee MA, Lee YB, Park IH. 2008b. Production and characterization of immortal human neural stem cell line with multipotent differentiation property. Methods Mol Biol 438:103-121.
105. Kim TE, Lee HS, Lee YB, Hong SH, Lee YS, Ichinose H, Kim SU, Lee MA. 2003. Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotype in Nurr-1 over-expressing neural stem cells. Biochem Biophys Res Commun 305:1040-1048.
106. Kish SJ, Shannak K, Hornykiewitcz O. 1988. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318:876-880.
107. Klein SM, Behrstock S, McHugh J, Hoffmann K, Wallace K, Suzuki M, Aebischer P, Svendsen CN. 2005. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 16:509-521.
108. Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, Jannetta P, DeCesare S, Elder EM, McGrogan M, Reitman MA, Bynum L. 2000. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55:565-569.
109. Kordower JH, Goetz CG, Freeman TB, Olanow CW. 1997a. Doparminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery. Exp Neurol 144:41-46.
110. Kordower JH, Chen EY, Winkler C, Fricker R, Charles V, Messing A, Mufson EJ, Wong SC, Rosenstein JM, Björklund A, Emerich DF, Hammang J, Carpenter MK. 1997b. Grafts of EGFresponsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease. J Comp Neurol 387:96-113.
111. Kosuga M, Sasaki K, Tanabe A, Li XK, Okawa H, Ogino I, Okuda O, Arai H, Sakuragawa N, Kamata Y, Azuma N, Suzuki S, Yamada M, Okuyama T. 2001. Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in MPS VII mice. Mol Ther 3:39-48.
112. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H. 2004. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 9:189-197.
113. Lachapelle F, Gumpel M, Baulac C, Jacque C. 1983. Transplantation of fragments of CNS into the brain of shiverer mutant mice: extensive myelination of transplanted oligodendrocytes. Dev Neurosci 6:326-334.
114. Lang AE, Lozano AM. 1998a. Parkinson's disease. First of two parts. N Engl J Med 339:1044-1053.
115. Lang AE, Lozano AM. 1998b. Parkinson's disease. Second of two parts. N Engl J Med 339:1130-1143.
116. Learish RD, Brustle O, Zhang SC, Duncan ID. 1999. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutants in widespread formation of myelin. Ann Neurol 46:716-722.
117. Lee HJ, Kim KS, Kim EJ, Choi HB, Lee KH, Park IH, Ko Y, Jeong SW, Kim SU. 2007a. Brain transplantation of human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model. Stem Cells 25:211-224.
118. Lee HJ, Kim KS, Kim EJ, Park IH, Kim SU. 2007b. Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One 1/e156:1-14.
119. Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. 2000. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18:675-679.
120. Lee ST, Chu K, Park JE, Lee K, Kang L, Kim SU, Kim M. 2005. Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model. Neurosci Res 52:243-249.
121. Lee ST, Park JE, Lee K, Kang L, Chu K, Kim SU, Kim M, Roh JK. 2006. Noninvasive method of immortalized neural stem-like cell transplantation in an experimental model of Huntington's disease. J Neurosci Methods 52:250-254.
122. Lee ST, Chu K, Jung KH, Kim SJ, Kim DH, Kang KM, Hong NH, Kim JH, Ban JJ, Park HK, Kim SU, Park CG, Lee SK, Kim M, Roh JK. 2008. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in hemorrhagic stroke. Brain 131:616-629.
123. Li P, Tessler A, Han SS, Fischer I, Rao MS, Selzer ME. 2005. Fate of immortalized human neuronal progenitor cells transplanted in rat spinal cord. Arch Neurol 62:223-229.
124. Li S, Tokuyama T, Yamamoto J, Koide M, Yokota N, Namba H. 2005. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther 12:600-607.
125. Li Y, Field PM, Raisman G. 1997. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277:2000-2002.
126. Lindvall O, Kokaia Z. 2006. Stem cells for the treatment of neurological disorders. Nature 441:1094-1096.
127. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, Marsden CD, et al. 1990. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577.
128. Lindvall O, Kokaia Z, Martinez-Serrano A. 2004. Stem cell therapy for human neurodegenerative disorders - how to make it work. Nat Med 10(Suppl):S42-S50.
129. Liu S, Qu Y, Stewart TJ, Howard MJ, Chakrabortty S, Holekamp TF, McDonald JW. 2000. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after transplantation. Proc Natl Acad Sci USA 97:6126-6131.
130. Liu Y, Kim D, Himes BT, Chow SY, Schallert T, Murray M, Tessler A, Fischer I. 1999. Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci 19:4370-4387.
131. Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, Rowitch DH. 2000. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25:317-329.
132. Marr RA, Rockenstein E, Mukherjee A, Kindy MS, Hersh LB, Gage FH, Verma IM, Masliah E. 2003. Neprilysin gene transfer reduces human amyloid patholgy in trasgenic mice. J Neurosci 23:1992-1996.
133. Marshak DR, Gardner RL, Gottlieb D. 2001. Stem cell biology. Cold Spiring Harbor, NY: Cold Spiring Harbor Laboratory Press.
134. Marshall J, Thomas DJ. 1988. Cerebrovascular disease. In: Asbury A, McKhann G, McDonald W, editors. Diseases of the nervous system. Philadelphia: W.B. Saunders. p 1101-1135.
135. Martinez-Serrano A, Bjorklund A. 1997. Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci 20:530-538.
136. Matsuoka N, Ishii K, Akimoto M, Hamada H, Hashimoto N, Miyatake S. 2002. Overexpression of basic fibroblast growth factor and Bcl-xL with adenoviral vectors protects primarily cultured neurons against glutamate insult. Neurosurgery 50:857-862.
137. McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN, Kordower JH. 2004. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol 475:211-219.
138. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW. 1999. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5:1410-1412.
139. McFarlin DE, McFarland HF. 1982. Multiple sclerosis. N Engl J Med 307:1183-1188.
140. McKay RG. 1997. Stem cells in the central nervous system. Science 276:66-71.
141. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. 1999. Prevalence of lysosomal storage disorders. JAMA 281:249-254.
142. Melchor JP, Pawlak R, Strickland S. 2003. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta degradation and inhibit Abeta-induced neurodegeneration. J Neurosci 23: 8867-8871.
143. Meng XL, Shen JS, Ohashi T, Maeda H, Kim SU, Eto Y. 2003. Brain transplantation of genetically engineered human neural stem cells transduced with beta-glucuronidase globally corrects lysosomal storage and brain lesions in mucopolysaccharidosis VII mice. J Neuosci Res74:266-277.
144. Miles GB, Yohn DC, Wichterle H. 2004. Functional properties of moto-neurons derived from mouse embryonic stem cells. J Neurosci 24: 7848-7858.
145. Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, Hersh LB, Thiele DL. 2003. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100:6221-6226.
146. Modo M, Stroemer RP, Tang E, Patel S, Hodges H. 2002. Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke 33:2270-2278.
147. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, Gan L. 2006. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzhemer's disease. Neuron 51:703-714.
148. Nagai A, Kim WK, Lee HJ, Jeong HS, Kim KS, Hong SH, Park IH, Kim SU. 2007. Multilineage potential of stable human mesenchymal stem cell line derived from fetal marrow. PLoS ONE 2/e1272:1-18.
149. Najbauer J, Danks MK, Kim SU, et al. 2008. Neural stem cell mediated tumor-selective gene delivery: toward high grade glioma clinical trials. Mol Ther 16(Suppl 1):S136.
150. Nakao N, Itakura T. 2000. Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits. Prog Neurobiol 61:313-338.
151. Noble LJ, Wrathall JR. 1989. Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat. Exp Neurol 103:34-40.
152. Ogawa Y, Sawamoto K, Miyata T, Miyao S, Watanabe M, Nakamura M, Bregman BS, Koike M, Uchiyama Y, Toyama Y, Okano H. 2002. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res 69:925-933.
153. Olanow CW, Kordower J, Freeman T. 1996. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19:102-109.
154. Packer RJ, Cogen P, Vezina G, Rorke LB. 1999. Medulloblastoma: clinical and biologic aspects. Neurooncology 1:232-50.
155. Panickar KS, Nonner D, Barrett JN. 2005. Overexpression of Bcl-xL protects septal neurons from prolonged hypoglycemia and from acute ischemia-like stress. Neuroscience 135:73-80.
156. Park IH, Zhao R, West JA, Yabuuchi A, Hu H, Ince TA, Lerou PH, Lensch MW, Daley GO. 2008. Reprogramming of human somatic cells to pluripotency
157. Patrice SJ, Tarbell NJ, Goumnerova LC, Shrieve DC, Black PM, Loeffler JS. 1995. Results of radiosurgery in the management of recurrent and residual medulloblastoma. Pediatr Neurosurg 22:197-203.
158. Paty D, Ebers GC. 1998. Multiple sclerosis. Philadelphia: F.A. Davis.
159. Pérez-Navarro E, Canudas AM, Akerund P, Alberch J, Arenas E. 2000. Brain-derived neurotrophic factor, NT-3 and NT-3/4 prevent the death of striatal projection neurons in rodent model of Huntington's disease. J Neurochem 75:2190-2199.
160. Redmond DE Jr, Bjugstad KB, Teng YD, Ourednik V, Ourednik J, Wakeman DR, Parsons XH, Gonzalez R, Blanchard BC, Kim SU, Gu Z, Lipton SA, Markakis EA, Roth RH, Elsworth JD, Sladek JR Jr, Sidman RL, Snyder EY. 2007. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA 104:12175-12180.
161. Reier PJ. 2004. Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx 1:424-451.
162. Renfranz PJ, Cunningham M, McKay R. 1991. Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell 66:713-729.
163. Roberts TJ, Price J, Williams SC, Modo M. 2006. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. Neuroscience 139:1187-1199.
164. Rowland LP, Shneider NA. 2001. Amyotrophic lateral sclerosis. N Engl J Med 344:1688-1700.
165. Ryu JK, Kim J, Cho SJ, Hatori K, Nagai A, Choi HB, Lee MC, McLarnon JG, Kim SU. 2004. Proactive transplantation of human neural stem cells blocks neuronal cell death in rat model of Huntington disease. Neurobiol Dis 16:68-77.
166. Ryu MY, Lee MA, Ahn YH, Kim KS, Yoon SH, Snyder EY, Cho KG, Kim SU. 2005. Brain transplantation of genetically modified neural stem cells in parkinsonian rat. Cell Transplant 14:193-202.
167. Sah DW, Ray J, Gage F. 1997. Bipotent progenitor cell lines from the human CNS. Nat Biotechnol 15:574-580.
168. Sanai N, Alvarez-Buylla A, Berger MS. 2005. Mechanisms of disease: neural stem cells and the origin of gliomas. N Engl J Med 353:811-822.
169. Saporta S, Borlongan CV, Sanberg PR. 1999. Neural transplantation of human teratocarcinoma neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery. Neuroscience 180:519-525.
170. Savitz SI, Rosenbaum DM, Dinsmore JH, Wechsler LR, Caplan LR. 2002. Cell transplantation for stroke. Ann Neurol 52:266-275.
171. Seilhean D, Gansmüller A, Baron-Van Evercooren A, Gumpel M, Lachapelle F. 1996. Myelination by transplanted human and mouse CNS tissue after long-term cryopreservation. Acta Neuropathol 91:82-88.
172. Shah K, Bureau E, Kim DE, Yang K, Tang Y, Weissleder R, Breakefield XO. 2005. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol 57:34-41.
173. Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD, Huggins GR, Gearhart JD. 1998. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 95:13726-13731.
174. Shim JW, Koh HC, Chang MY, Roh E, Choi CY, Oh YJ, Son H, Lee YS, Studer L, Lee SH. 2004. Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-xL. J Neurosci 24:843-852.
175. Shimato S, Natsume A, Takeuchi H, Wakabayashi T, Fujii M, Ito M, Ito S, Park IH, Bang JH, Kim SU, Yoshida J. 2007. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene Ther 15:1132-1142.
176. Sinden JD, Rashid-Doubell F, Kershaw TR, Nelson A, Chadwick A, Jat PS, Noble MD, Hodges H, Gray JA. 1997. Recovery of spatial learning by grafts of a conditionallyt immortalized hippocampal neuroepithelial cell line into the ischemia-lesioned hippocampus. Neuroscience 23:599-608.
177. Sly WS, Vogler C. 2002. Brain directed gene therapy for lysosomal storage disease: going well beyond the blood-brain barrier. Proc Natl Acad Sci USA 99:5760-5762.
178. Snyder EY, Deitcher DL, Walsh C. 1992. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68: 33-51.
179. Snyder EY, Taylor RM, Wolfe JH. 1995. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374:367-370.
180. Springer JE, Azbill RD, Knapp PE. 1999. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat Med 5:943-946.
181. Streck CJ, Dickson PV, Ng CY, Zhou J, Hall MM, Gray JT, Nathwani AC, Davidoff AM. 2006. Antitumor efficacy of AAV-mediated delivery of Interferon-beta. Cancer Gene Ther 13:99-106.
182. Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, Van Damme P, Rutten B, Man WY, De Mol M, Wyns S, Manka D, Vermeulen K, Van Den Bosch L, Mertens N, Schmitz C, Robberecht W, Conway EM, Collen D, Moons L, Carmeliet P. 2005. Treatment of motoneuron degeneration by intracerebro-ventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 8:85-92.
183. Studer L, Tabar V, McKay R. 1998. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1:290-295.
184. Takagi Y, Takahashi J, Saiki H, Morizane A, Hayashi T, Kishi Y, Fukuda H, Okamoto Y, Koyanagi M, Ideguchi M, Hayashi H, Imazato T, Kawasaki H, Suemori H, Omachi S, Iida H, Itoh N, Nakatsuji N, Sasai Y, Hashimoto N. 2005. Dopaminergic neurons generated from monkey ES cells function in a Parkinson primate model. J Clin Invest 115:102-108.
185. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
186. Takebayashi H, Yoshida S, Sugimori M, Kosako H, Kominami R, Nakafuku M, Nabeshima Y. 2000. Dynamic expression of bHLH Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mech Dev 99:143-148.
187. Taylor RM, Wolfe JH. 1997. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of betaglucuronidase. Nat Med 3:771-774.
188. Temple S. 2001. The development of neural stem cells. Nature 414:112-117.
189. Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, Langer R, Snyder EY. 2002. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 99:3024-3029.
190. Thieben MJ, Duggins AJ, Good CD, Gomes L, Mahant N, Richards F, McCusker E, Frackowiak RS. 2002. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 125:1815-1828.
191. Thompson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. 1998. Embryonic stem cell line derived from human blastocysts. Science 282:1145-1147.
192. Tuszynski MH. 2002. Gene therapy for neurodegenerative disorders. Lancet Neurol 1:51-57.
193. Tuszynski MH, U HS, Amaral DG, Gage FH. 1990. Nerve growth factor infusion in primate brain reduces lesion-induced cholinergicneuronal degeneration. J Neurosci 10:3604-3614.
194. Tuszynski MH, Peterson DA, Ray J, Baird A, Nakahara Y, Gage FH. 1994. Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord. Exp Neurol 126:1-14.
195. Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J. 2005. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11:551-555.
196. Veizovic T, Beech JS, Stroemer RP, Watson WP, Hodges H. 2001. Resolution of stroke deficits following contalateral grafts of conditionally immortlized neuroepithelial stem cells. Stroke 32:1012-1019.
197. Visnyei K, Tatsukawa KJ, Erickson RI, Simonian S, Oknaian N, Carmichael ST, Kornblum HI. 2006. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Exp Neurol 197:465-474.
198. Wagner J, Akerud P, Castro DS, Holm PC, Canals JM, Snyder EY, Perlmann T, Arenas E. 1999. Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nat Biotechnol 17:653-659.
199. Watabe K, Ohashi T, Sakamoto T, Kawazoe Y, Takeshima T, Oyanagi K, Inoue K, Eto Y, Kim SU. 2000. Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor. J Neurosci Res 60:511-519.
200. Wichterle H, Lieberam I, Porter JA, Jessell TM. 2002. Directed differentiation of embryonic stem cells into motor neurons. Cell 110:385-397.
201. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. 1981. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122-126.
202. Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G, Roy NS, Goldman SA. 2004. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 10:93-97.
203. Wolff JA, Fisher LJ, Xu L, Jinnah HA, Langlais PJ, Iuvone PM, O'Malley KL, Rosenberg MB, Shimohama S, Friedmann T, et al. 1989. Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci USA 86:9011-9014.
204. Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, Hatfield G, Koliatsos VE. 2006. Human neural stem cell grafts ameliorate motor neuron disease in SOD1 transgenic rats. Transplantation 82:865-875.
205. Xu XM, Guenard V, Kleitman N, Aebischer P, Bunge MB. 1995. A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 134:261-272.
206. Yandava B, Billinghurst L, Snyder E. 1999. Global cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 96:7029-7034.
207. Yang CR, Yu RK. 2009. Intracerebral transplantation of neural stem cells combined with trehalose ingetion alleviates pathology in a mouse model of Huntington's disease. J Neurosci Res 87:26-33.
208. Yang SY, Liu H, Zhang JN. 2004. Gene therapy of rat malignant glioma using neural stem cells expressing IL-12. DNA Cell Biol 23:381-389.
209. Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, Maki M, Kim SU, Borlongan CV. 2006. Transplantation of neural stem cells exerts neuroprotection in a rat model of Parkinson disease. J Neurosci 26:124497-12511.
210. Yoshida J, Mizuno M, Wakabayashi T. 2004. Interferon-β gene therapy for cancer: basic research to clinical application. Cancer Sci 95:858-865.
211. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz J, Frane JL, Tian S, Nie J, Jonsdottier GA, Ruotti V, Stewart R, Slukvin I, Thomson JA. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
212. Yuan J, Yankner BA. 2000. Apoptosis in the nervous system. Nature 407:802-809.
213. Zhang SC, Ge B, Duncan ID. 1999. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. Proc Natl Acad Sci USA 96:4089-4094.
214. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC. 2002. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischmica brain of rats. Exp Neurol 174:11-20.
215. Zheng C, Nennesmo I, Fadeel B, Henter JI. 2004. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol 56:564-567.
216. Zhou Q, Wang S, Anderson DJ. 2000. Identification of a novel family of oligodendrocyte lineage specific basic helix loop helix transcription factors. Neuron 25:331-343.